Insulin resistance can be improved with resveratrolNew York City, N.Y, September 8, 2011 — A recent study has been conducted by the University of Alberta, Canada, into the effect resveratrol can have on metabolic syndrome in adolescent rats.
The aim of the study was to see if the administration of resveratrol to rats who had poor growth development during pregnancy, could help to strengthen their metabolic profile and avoid the dangers of metabolic syndrome, which include glucose tolerance and insulin resistance, pre-cursors to developing type 2 diabetes, coronary problems and strokes.
The study details, published in Diabetes, took male rats that were in the last period of gestation and either exposed them to 21% or 11.5% of oxygen. This lack of oxygen is called hypoxic insult and can lead to growth restrictions and the early onset of metabolic syndrome.
The two groups of male rats, after weaning, were then given a high fat diet each, with one group also having resveratrol supplemented to their meals for a period of nine weeks.
The results showed that the rats that were oxygen depraved had increased signs of metabolic syndrome while the resveratrol fed group had an improved lipid profile plus more balanced glucose tolerance and insulin resistance levels.
The researchers commented: “Our results suggest that early, post natal administration of resveratrol could improve the metabolic profile of high-fat fed offspring born from pregnancies complicated by intrauterine growth restriction.”
Mary Green, spokesperson for muscadine grape extract supplier, Muscadinex, commented: “Its good to see that another facet of resveratrol’s health potential being unlocked. We have long believed that the muscadine contains a lot of health benefits including cognitive, cardio and anti-inflammatory. This is why we have developed Muscadinex, 650mg of pure muscadine grape seed extract full of resveratrol, ellagic acid and quercetin plus many other beneficial polyphenols.”
Muscadinex is made from the seeds of the fruit. It’s a labor intensive process, but the results are worthwhile. A total of 88 phenolic compounds have been identified in muscadines with seventeen compounds being identified for the first time. The compounds identified in seeds include flavanols, ellagic acid, quercetin and resveratrol, plus muscadine is the only grape to have resveratrol in the seeds.
The Muscadinex spokesperson continued: “Most polyphenol supplements give a large dose of just one isolated and processed molecule. But because Muscadinex is made only from fresh Muscadine grape seeds, you get a full spectrum of polyphenols, antioxidants and bio-flavonoids, all which work in synergy to create optimum health results.”
To read more about Muscadinex and resveratrol, visit http://www.muscadinex.com/product/muscadinex/
About Muscadinex … and free gift news.
Muscadinex is a 100% natural extract of all American muscadine grape seed. The product is harvested and bottled in FDA inspected facilities on the farm in North Carolina. Each Muscadinex capsule contains 650mg of extract, containing the natural proportions of resveratrol, ellagic acid, quercetin and 100 other polyphenols. There are no additives or fillers.
You can purchase Muscadinex on our website with secure Paypal payments … or from Amazon or eBay. The price of Muscadinex is $29.99 (plus delivery) for 60 capsules of 650mg pure muscadine extract.
With every bottle of Muscadinex you also receive a free gift of a family-size bottle of 100 capsules of vitamin D3. Each softgel capsule has 5000iu of vitamin D3. This is the most natural, bioavailable form of vitamin D.
Other press releases from Muscadinex
- Ellagic Acid From Muscadine Grapes Can Combat Oxidative Stress in Diabetic Rats - September 29th, 2011
- Resveratrol and Quercetin Can Help With Obesity and Osteoperosis - September 23rd, 2011
- Resveratrol and ellagic acid are successful at combating skin cancer when combined - September 2nd, 2011
- Could Resveratrol Help Combat Breast Cancer - August 23rd, 2011
- Resveratrol reverses alcohol induced damage - August 17th, 2011